FullerLC, 2013.Epidemiology of scabies,Curr Opin Infect Dis 26 123 -6
HeukelbachJ,MazigoHD,UgbomoikoUS, 2013.Impact of scabies in resource-poor communities,Curr Opin Infect Dis 26 127 -32
HayRJ,SteerAC,EngelmanD,WaltonS., 2012.Scabies in the developing world--its prevalence, complications, and management,Clin Microbiol Infect 18 313 -23
MicaliG,LacarrubbaF,VerzìAE,NascaMR, 2015.Low-cost equipment for diagnosis and management of endemic scabies outbreaks in underserved populations,Clin Infect Dis 60 327 -9
LeungV,MillerM., 2011.Detection of scabies: A systematic review of diagnostic methods,Can J Infect Dis Med Microbiol 22 143 -6
Le CleachL,ChosidowO., 2011.Commentary on "Interventions for treating scabies",Evid Based Child Health 1865 -6
RanjkeshMR,NaghiliB,GoldustM,RezaeeE., 2012.The efficacy of permethrin 5% vs. oral ivermectin for the treatment of scabies, 59 189 -94
LokugeB,KopczynskiA,WoltmannA,AlvoenF,ConnorsC,GuyulaT, 2014.Crusted scabies in remote Australia, a new way forward: lessons and outcomes from the East Arnhem Scabies Control Program,Med J Aust 200 644 -8
GonzalezP,GonzálezF,UenoK., 2012.Ivermectin in human medicine, an overview of the current status of its clinical applications,Curr Pharm Biotechnol 13 1103 -9
ThuanNH,PandeyRP,SohngJK, 2014.Recent advances in biochemistry and biotechnological synthesis of avermectins and their derivatives,ApplMicrobiolBiotechnol 98 7747 -59
ŌmuraS,CrumpA, 2014.Ivermectin: panacea for resource-poor communities? Trends Parasitol, 30 445 -55
WebsterJP,MolyneuxDH,HotezPJ,FenwickA, 2014.The contribution of mass drug administration to global health: past, present and future,Philos Trans R Soc LondB Biol Sci 369 20130434 -
RizviSDA,IftikharN,BatoolF, 2011.Effectiveness of oral ivermectin for eradicating infesting mites in patients of scabies,J Pak Assoc Dermatol 21 87 -92
GoldustM,RezaeeE,RaghifarR, 2013.Treatment of scabies: the topicalivermectin vs,permethrin 2 59 79 -84
ChhaiyaSB,PatelVJ,DaveJN,MehtaDS,ShahHA, 2012.Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies,Indian J Dermatol Venereol Leprol 78 605 -10
AlasaadS,RossiL,HeukelbachJ,PérezJM,HamarshehO,OtiendeM, 2014.The neglected navigating web of the incomprehensibly emerging and re-emerging Sarcoptes mite,Infect Genet Evol 17 253 -9
AndriantsoanirinaV,IzriA,BotterelF,FouletF,ChosidowO,DurandR, 2014.Molecular survey of knockdown resistance to pyrethroids in human scabies mites,Clin Microbiol Infect 20 O139 -O141
DongK,DuY,RinkevichF,NomuraY,XuP,WangL, 2014.Molecular biology of insect sodium channels and pyrethroid resistance,Insect Biochem Mol Biol 50 1 -17
FischerK,HoltD,CurrieB,KempD, 2012.Important clinical consequences explained by new molecular studies,AdvParasitol 79 339 -73
ChhaiyaSB,MehtaDS,KatariaBC, 2012.Ivermectin: pharmacology and therapeutic applications,Int J Basic Clin Pharmacol 1 132 -9
AggarwalG,RathorePK, 2014.Comparative study to test efficacy of topical permethrin and oral ivermectin in the management of scabies-a prospective randomized, single blinded controlled study,Nat J Integ ResMed 5 57 -60
StoevesandtJ,CarléL,LeverkusM,Hamm H, 2012.Control of large institutional scabies outbreaks,J Dtsch Dermatol Ges 10 637 -47
WorthC,FenglerG,WalterB,LiesenfeldO, 2012.Acute morbidity associated with scabies and other ectoparasitoses rapidly improves after treatment with ivermectin,Pediatr Dermatol 29 430 -6
ElstonCA,ElstonDM, 2013.Treatment of common skin infections and infestations during pregnancy,Dermatol Ther 26 312 -20
ButlerDC,HellerMM,MuraseJE,Lactation. J AmAcad Dermatol, 2014.Safety of dermatologic medications in pregnancy and lactation: Part II, 70 417 -e1
FujimotoK,KawasakiY,MorimotoK,KikuchiI,KawanaS, 2014.Treatment for crusted scabies: limitations and side effects of treatment with ivermectin,J Nippon Med Sch 81 157 -63
ManjhiPK,SinhaRI,KumarM,SinhaKI, 2014.Comparative study of efficacy of oral ivermectin versus some topical antiscabies drugs in the treatment of scabies,JClin DiagnRes 8 HC01 -4
HaasN,LindemannU,FrankK,SterryW,LademannJ,KatzungW. Rapid, 2002.and preferential sebum secretion of ivermectin: a new factor that may determine drug responsiveness in patients with scabies,Arch Dermatol 138 1618 -9
KomodaM,AkagiK,YuzawaK,YoshimasuT,YamamotoY, 2015.Experimental study of pharmacokinetics of external, whole‐body bathing application of ivermectin,J Dermatol 42 87 -89
WaltonSF,MyerscoughMR,CurrieBJ, 2000.Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var,hominis. Trans R Soc Trop Med Hyg 94 92 -6